ja:
  protocols:
    index:
      protocol_title: プロトコルタイトル
      my_role: 自分の役割
      principal_investigator: 主任研究員
      status: 状態
      version: バージョン
      filter: プロトコルをフィルタリング
    new:
      title: プロトコル新規作成
      back: 戻る
    edit:
      title: プロトコル編集
      show: 詳細
      back: 戻る
    show:
      protocol: プロトコル
      editor: エディタ
      admin: 管理者
      edit_title: プロトコル編集
      edit: 編集
      back: 戻る
    form:
      error_message: '%{count} 件のエラーが発生しました。'
    step:
      one:
        step: ステップ 1 / 3
        next: 次へ
        one: 1) 臨床試験の名前またはタイトルは何ですか？
        two: 2) 該当する場合は、短いタイトルは何ですか？
        three: 3) プロトコル識別番号は何ですか？
        four: 4) 可能であれば、国立臨床試験（NCT）識別番号は何ですか？
        five: 5) IND / IDEスポンサーの名前は何ですか？ （Ctrlを押しながらクリックして複数選択）
        five_a: 5a) 「その他」を選択した場合、そのIND / IDEスポンサーの名前は何ですか？
        six: 6) 臨床試験に資金を提供している企業の名前は何ですか？
        seven: 7) 研究薬剤は薬物、生物学的物質、または装置ですか？
        drug: 薬物
        biologic: 生物製剤
        device: 機器
        has_ide: IDEを入手しましたか？
        has_ind: INDを入手しましたか？
        'yes': はい
        'no': いいえ
        error: タイトルを入力してください
        sponsors:
          - National Cancer Institute
          - National Institute of Allergy and Infectious Diseases
          - National Institute of Dental and Craniofacial Research
          - National Institute of Diabetes and Digestive and Kidney Diseases
          - National Heart, Lung, and Blood Institute
          - National Institute of Mental Health
          - National Institute of Neurological Disorders and Stroke
          - National Library of Medicine
          - National Institute of Child Health and Human Development
          - National Institute of General Medical Sciences
          - National Eye Institute
          - National Institute of Environmental Health Sciences
          - National Institute on Alcohol Abuse and Alcoholism
          - National Institute on Drug Abuse
          - National Institute on Aging
          - National Institute of Arthritis and Musculoskeletal and Skin Diseases
          - National Institute of Nursing Research
          - National Institute on Deafness and Other Communication Disorders
          - National Human Genome Research Institute
          - National Institute of Biomedical Imaging and Bioengineering
          - National Institute on Minority Health and Health Disparities
          - Center for Scientific Review
          - Clinical Center
          - National Center for Advancing Translational Sciences
          - Center for Information Technology
          - John E.Fogarty International Center
          - National Center for Complementary and Integrative Health
          - Other
      two:
        step: ステップ 2 / 3
        prev: 前へ
        next: 次へ
        one: |-
          1) コンプライアンス声明は、人間の被験者に関する研究に必要です。 NIH Office of Science Policyは、以下にあるコンプライアンスのステートメントの1つを使用することを推奨しています。<br>
          <br>
          ご希望のものをお選びください：
        or: もしくは
        radio_one: |-
          The trial will be carried out in accordance with International Conference on Harmonisation
          Good Clinical Practice (ICH GCP) and the following:
          <br><br>
          <ul><li>
          United States (US) Code of Federal Regulations (CFR) applicable to clinical studies
          (45 CFR Part 46, 21 CFR Part 50, 21 CFR Part 56, 21 CFR Part 312, and/or 21 CFR Part 812)
          </li></ul>
          National Institutes of Health (NIH)-funded investigators and clinical trial site staff who
          are responsible for the conduct, management, or oversight of NIH-funded clinical trials have
          completed Human Subjects Protection and ICH GCP Training.
          <br><br>
          The protocol, informed consent form(s), recruitment materials, and all participant materials
          will be submitted to the Institutional Review Board (IRB) for review and approval.
          Approval of both the protocol and the consent form must be obtained before any participant
          is enrolled.
          Any amendment to the protocol will require review and approval by the IRB before the changes
          are implemented to the study.
          In addition, all changes to the consent form will be IRB-approved; a determination will be
          made regarding whether a new consent needs to be obtained from participants who provided
          consent, using a previously approved consent form.
        radio_two: |-
          The trial will be conducted in accordance with International Conference on Harmonisation Good
          Clinical Practice (ICH GCP), applicable United States (US) Code of Federal Regulations (CFR),
          and the [specify NIH Institute or Center (IC)] Terms and Conditions of Award.
          The Principal Investigator will assure that no deviation from, or changes to the protocol
          will take place without prior agreement from the Investigational New Drug (IND) or Investigational
          Device Exemption (IDE) sponsor, funding agency and documented approval from the Institutional
          Review Board (IRB), except where necessary to eliminate an immediate hazard(s) to the trial
          participants.
          All personnel involved in the conduct of this study have completed Human Subjects Protection
          and ICH GCP Training.
          <br><br>
          The protocol, informed consent form(s), recruitment materials, and all participant materials
          will be submitted to the IRB for review and approval.
          Approval of both the protocol and the consent form must be obtained before any participant
          is enrolled.
          Any amendment to the protocol will require review and approval by the IRB before the changes
          are implemented to the study.
          All changes to the consent form will be IRB approved; a determination will be made regarding
          whether a new consent needs to be obtained from participants who provided consent, using a
          previously approved consent form.
      three:
        step: ステップ 3 / 3
        prev: 前へ
        build: チームを作成する
        user: ユーザー
        role: 役割
        sections: セクション
    menu:
      example: 例
      instructions: 説明
      sections: セクション
      title_page: タイトルページ
    editor:
      editor: エディタ
      section_title: タイトルページ(読み出し専用)
      principal_investigator: 主任研究員
      draft_number: バージョン
    create:
      success: プロトコルを作成しました。
    update:
      success: プロトコルを更新しました。
    destroy:
      success: プロトコルを削除しました。
